Navigation Links
Novel marker helps identify preeclampsia risk in pregnancy
Date:3/7/2013

SAN FRANCISCO (March 7, 2013) Pregnant women who have a reduced number of capillaries under their skin during pregnancy may be at heightened risk for preeclampsia, according to research being presented at the American College of Cardiology's 62nd Annual Scientific Session. Researchers say monitoring such changes in small blood vessels early in pregnancy may allow for medical intervention long before the potentially life-threatening condition occurs.

The study, conducted by researchers in England, evaluated 305 women early in pregnancy to determine whether measuring and tracking the number of capillariestiny blood vessels that pass blood from arteries to veinsat various points throughout pregnancy could help predict which women would be likely to develop preeclampsia. This research builds on a previous study in 2001 by the same research team in women with established preeclampsia late in pregnancy. In this earlier study, researchers noticed that women with the condition had a significantly fewer number of capillaries compared to expectant moms without preeclampsia.

Researchers now find that among pregnant women who developed preeclampsia later in pregnancy, the number of capillaries was reduced early oneven at 20 weeks of pregnancy. Data show that using this novel, simple measure seemed to identify those women likely to develop preeclampsia 87 percent of the timean improvement to the currently used screening test. Repeating the test during the course of pregnancy at or after 27 weeks gestation accurately identified the condition 75 percent of the time and was less likely to include women who would not go on to develop the condition.

"We found that the predictive value of measuring [relative] changes in the capillaries far exceeds that of [the uterine Doppler] scan that is currently used," said Tarek Antonios, MD, St. George's, University of London, and the study's lead investigator. "If the results of this research are confirmed in a larger study, this technique could change clinical practice and be used as a novel way to predict preeclampsia so that more timely medical care can be provided to these pregnant women and prevent thousands of women and hundreds of thousands of infants from dying from this disease."

Preeclampsia is characterized by a rapid rise in blood pressure, leakage of protein in the urine and swelling of the legs after the 20th week of pregnancy. While the exact cause of preeclampsia is not fully understood, there is increasing evidence to suggest widespread abnormalities in the small blood vessels, called microcirculation, before the onset of preeclampsia. When capillaries are blocked or reduced in number, normal blood flow is obstructed and affected body tissues can suffer from lack of enough oxygen. This lack of oxygen (or hypoxia) is thought to be the trigger of the abnormalities that cause preeclampsia.

Preeclampsia affects up to 7 percent of all pregnancies. It is also the second leading cause of death during pregnancy behind complications of the delivery itself. The condition can damage blood vessels in the body and, if untreated, increases the risk of developing eclampsia, which in Greek means flashing light or lightening because of its sudden onset. Eclampsia can result in dangerous seizures, stroke and multiple organ failure. In addition to its deleterious effects on expectant moms, preeclampsia can also cut off blood supply to the fetus and result in premature birth or even death. Dr. Antonios said that many women in developing countries die from this condition shortly after the diagnosis because they cannot get adequate medical care or because it is too late to respond to treatment.

Currently, a uterine artery Doppler scan is used to determine a woman's risk of preeclampsia by evaluating blood flow through the artery in the uterus. However, Dr. Antonios says this test is only 50 percent accurate. In this study, researchers measured skin capillary density according to a well-validated protocol at five consecutive, predetermined visits in 322 consecutive Caucasian women, of which 305 subjects completed the study.

"We found that if we examine the microcirculation and measure the changes in capillaries we can predict preeclampsia in a more accurate way and this is exciting news," Dr. Antonios said. "This evaluation is totally non-invasive, painless and takes only 20 minutes while the patient sits comfortably with their hand under a specially designed microscope."

He adds that combining this new approach with the uterine artery Doppler pulsatility index increased the overall accuracy of the prediction.

While the odds of preeclampsia are increased in women with previous history of preeclampsia or chronic high blood pressure and among those with increased uterine artery Doppler pulsatility index, the most powerful and independent predictor of preeclampsia was capillary rarefaction at 27-32 weeks. Other known risk factors for preeclampsia include age over 40 years, first pregnancy, carrying multiple fetuses, being overweight, having diabetes mellitus or chronic kidney disease, or having family history of preeclampsia.

Dr. Antonios says a larger study is needed to validate these initial results and should include a more diverse sample of women.


'/>"/>

Contact: Beth Casteel
bcasteel@acc.org
240-328-4549
American College of Cardiology
Source:Eurekalert

Related medicine news :

1. Novel compound demonstrates anti-leukemic effect in zebrafish, shows promise for human treatment
2. Rutgers team discovers novel approach to stimulate immune cells
3. Novel drug candidates offer new route to controlling inflammation
4. Researchers present new findings for novel pancreatic cancer vaccine
5. Novel biomarkers reveal evidence of radiation exposure
6. VCU Massey Cancer Center sees potential in novel leukemia treatment
7. Study supports urate protection against Parkinsons disease, hints at novel mechanism
8. Novel Natural Sciences Repository Opens Web Portal
9. Novel Anti-Inflammatories May Offer a New Approach for the Treatment of Stroke
10. LA BioMed investigators, Drs. Kevin Bruhn and Noah Craft, develop novel treatment for melanoma
11. Novel radiation therapy safely treats prostate cancer and lowers the risk of recurrence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... 08, 2016 , ... ZyDoc , a New York-based ... Data Capture Methods for Input to Electronic Health Records: A Comparative Usability Study” ... comparative usability study demonstrate that a dictation-based method (“NLP Entry”) using ZyDoc’s MediSapien™ ...
(Date:12/8/2016)... ... December 08, 2016 , ... CURE Media Group, the nation’s leading digital and ... with Upstage Lung Cancer in efforts to combat lung cancer, announced CURE Media Group ... said, “CURE Media Group is honored to team up with Upstage Lung Cancer in ...
(Date:12/8/2016)... ... 2016 , ... Premier Fitness Camp (PFC) and The Chopra Center for Wellbeing ... wellness program, at their world headquarters of Omni La Costa Resort & Spa in ... anyone seeking weight loss, personal development, a healthy lifestyle, or mental and physical healing. ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... development solutions for drugs, biologics and consumer health products, today announced that it ... up in 2006 as a non-profit organization to unite pharmaceutical and healthcare companies ...
(Date:12/8/2016)... ... ... California Senate Bill (SB) 863, signed into law in 2012, may have ... according to CompScope™ Medical Benchmarks for California, 17th Edition , a study by ... payments per claim in California decreased 4 percent in 2013 and then 3 percent ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016 True Health ... brings leading-edge laboratory services and management expertise to ... , allowing more doctors and patients to ... management solutions. Logo - http://photos.prnewswire.com/prnh/20161208/447162LOGO ... Hospital systems, under pressure to contain costs, have ...
(Date:12/8/2016)... Research and Markets has announced the addition of the ... ... The global chromatography market to grow at a CAGR of 5.42% during ... prepared based on an in-depth market analysis with inputs from industry experts. ... coming years. The report also includes a discussion of the key vendors ...
(Date:12/8/2016)... , December 8, 2016 ... "Sugar-Based Excipients Market by Product (Actual Sugars, Sugar ... (Filler & Diluent, Tonicity Agents), Formulation (Oral, Topical, ... MarketsandMarkets, the market has witnessed healthy growth during ... at a CAGR of 4.3% between 2016 and ...
Breaking Medicine Technology: